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Abstract 
Approximately 20% of the UK population wear some form of denture prosthesis, 
resulting in denture stomatitis in half of these individuals. Candida albicans is 
primarily attributed as the causative agent, due to its biofilm forming ability. Recently, 
there has been increasing evidence of C. albicans biofilm heterogeneity and the 
negative impact it can have clinically; however, this phenomenon has yet to be 
studied in relation to denture isolates. The aims of this study were to evaluate C. 
albicans biofilm formation of clinical denture isolates in a denture environment, and 
assess antimicrobial activity of common denture cleansers against these tenacious 
communities. C. albicans isolated from dentures of healthy and diseased individuals 
was quantified using real-time polymerase chain reaction and biofilm biomass 
assessed using crystal violet. Biofilm development on the denture substratum 
poly(methyl methacrylate), Molloplast B and Ufi-gel was determined. Biofilm 
formation was assessed using metabolic and biomass stains, following treatment 
with denture hygiene products. Although C. albicans was detected in greater 
quantities in diseased individuals, it was not associated with increased biofilm 
biomass. Denture substrata were shown to influence biofilm biomass, with 
poly(methyl methacrylate) providing the most suitable environment for C. albicans to 
reside. Of all denture hygiene products tested, Milton had the most effective 
antimicrobial activity, reducing biofilm biomass and viability the greatest. Overall, our 
results highlight the complex nature of denture related disease, and disease 
development cannot always be attributed to a sole cause. It is the distinct 
combination of various factors that ultimately determines the pathogenic outcome.   
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Introduction 
It is estimated that 1 in 5 adults in the UK wear some form of dental prosthesis (1). 
Given that such a large proportion of the adult population wear a denture, then 
denture-related oral disease is a substantial healthcare problem. Denture stomatitis 
(DS) is considered the most common disease to afflict denture wearers, and has 
been shown to affect approximately 50% of this population (2). Candida spp., 
primarily C. albicans, are generally acknowledged as the principal microbial agents 
driving the pathogenesis of DS (3), although other species such as C. glabrata are 
frequently co-isolated (4). C. albicans is able to adhere to the denture surface and 
form complex microbial communities known as biofilms (5), surrounded by an 
extracellular matrix (ECM), which confers protection from antimicrobials (6, 7). These 
tenacious structures have been shown to adhere strongly to the denture. However, 
the details of such surface interactions are not yet fully understood (8, 9). Moreover, 
this problem is further compounded by the fact that C. albicans biofilms are clinically 
heterogeneous, and this phenotype has been shown to negatively impact patient 
outcomes (10-12). Whether this clinical heterogeneity plays a role in the intra-oral 
denture environment remains to be determined, as the influence of denture surfaces 
and methods of decolonisation needs to be considered.  
Poly (methyl methacrylate) (PMMA) is clinically the most commonly used denture 
material due to low cost and easy manipulation, despite its varied topography, which 
positively influences microbial colonisation and biofilm development (13-15). PMMA 
is a rigid material that, when in close contact with the mucosa, can cause discomfort. 
Therefore, the demand for softer, less rigid materials is becoming increasingly 
popular. These include resilient soft liners such as silicone- and acrylic-based liners, 
which have been shown to improve patient masticatory function and reduce pain and 
the appearance of sore spots within the oral cavity (16, 17). However, these liners 
are not resistant to the colonisation of microorganisms, complicating denture hygiene 
even further (14, 18). A number of over-the-counter (OTC) denture cleansers are 
widely available, though clinical guidelines advising on the most appropriate 
cleansing regimen are varied and lack a comprehensive evidence base. Denture 
cleansing alone has demonstrated a significant reduction in microbial viability and 
biomass, though a reservoir of cells remain upon the surface (19). Combining 
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mechanical and chemical intervention can further aid the control of biofilm formation 
on PMMA, though again residual biofilm cells are still capable of persisting (20, 21). 
The primary objective of this study was to determine whether quantitative (numbers 
of biofilm cells) or qualitative (biofilm phenotypic heterogeneity) factors from C. 
albicans were the primary drivers of denture stomatitis. A secondary objective was to 
evaluate whether the biofilm phenotype was influenced by an in vitro denture 
environment and denture hygiene treatment. Here we report that C. albicans isolates 
from dentures are quantitatively associated with disease but not biofilm 
heterogeneity. In vitro modelling revealed that a denture-related environment 
impacts biofilm heterogeneity, and how these respond to denture hygiene products. 
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Methods 
Patient sampling 
Samples for this study were obtained from 129 denture wearers attending the 
Glasgow Dental Hospital and School for routine treatment, as previously described 
by our group (22). Written informed consent was obtained from all participants. 
Ethical approval was granted by the West of Scotland Research Ethics Service 
(12/WS/0121) for the recruitment of participants to this study, where a clinician was 
responsible for the collection of clinical samples. The presence or absence of DS 
was assessed by the clinician, and those patients with DS were grouped according 
to Newton’s classification (23). The following scores were applied: 0 for healthy 
mucosa, 1 for pin-point hyperaemic lesions (localised erythema); 2 for diffuse 
erythema (generalised simple inflammation); and 3 for hyperplastic granular surface 
(inflammatory papillary hyperplasia). Patients were excluded from this study if they 
had been receiving antimicrobial treatment or using prescription mouthwashes within 
six months prior to sampling. Dentures were removed from the patient’s mouth and 
placed in sterile bags (Fisher Scientific) filled with 50 ml phosphate buffered saline 
([PBS, Sigma-Aldrich), and placed in a sonic bath (Ultrawave) for 5 min to remove 
the biofilm from the surface (24). The denture sonicate was centrifuged for 10 min at 
3700 x g [6000 r.p.m.], and the plaque pellet resuspended in 2 ml of RNAlater® 
(Qiagen) and stored at -80 °C. 
 
Molecular quantification of Candida in clinical samples 
The presence of Candida spp. isolated from healthy (n=81) and DS (n=48) patients 
was assessed by quantitative PCR (qPCR) by amplifying the Candida specific 18S 
gene. DNA was extracted using the QIAamp® DNA mini extraction kit (Qiagen) 
according to manufacturer’s instructions, with a minor modification to include a 
mechanical disruption step with sterile acid-washed glass beads of 0.5 mm diameter 
(Thistle Scientific). This was achieved by beating the samples for 3 × 30 s on a Mini-
BeadBeater (Sigma-Aldrich), while intermittently being placed with intermittent 
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cooling. DNA quality and quantity was quantified using the NanoDrop® 
spectrophotometer (ThermoScientific). 
To quantify Candida from each sample, 1 µl of DNA was added to a mastermix 
containing SYBR® GreenER™ (Life Technologies), UV-treated RNase-free water and 
18S forward/reverse primers (10 µM, Forward - CTCGTAGTTGAACCTTGGGC; 
Reverse - GGCCTGCTTTGAACACTCTA (25)), as per manufacturer’s instructions. 
The thermal profile used consisted of 50 °C for 2 min, 95 °C for 2 min followed by 40 
cycles of 95°C for 3 s and 60 °C for 30 s using a StepOne Plus real-time PCR unit 
(Applied Biosciences). Cycle threshold (Ct) values were used to approximate the 
number of corresponding colony forming equivalents (CFE’s) based on standard 
curves (Supplementary Figure 1). 
 
Standardised Candida albicans biofilm assessment 
To detect and identify the Candida species present, 100 µl of the denture sonicate 
was spread across Colorex Candida agar (E & O labs) and incubated at 30 °C for 72 
h. All clinical isolates obtained during this study were stored in Microbank® vials (Pro-
Lab Diagnostics, Cheshire, UK) at −80 °C, until required. Isolates identified as C. 
albicans from healthy (n=31) and DS (n=37) patients were propagated in yeast 
peptone dextrose (YPD) medium (Sigma-Aldrich), incubated at 30 °C, and vortexed 
150 r.p.m. for 18 h. Following incubation, cultures were washed twice by 
centrifugation, standardised, and grown statically at 37 °C for 24 h in 96 well flat-
bottomed polystyrene plates (Corning Incorporated), and assessed for biofilm 
formation as previously described (10, 26). Each isolate was tested in triplicate and 
negative controls containing no C. albicans were also included. Following incubation, 
biofilms were carefully washed twice with PBS to remove any non-adherent cells, 
before biomass was assessed using the crystal violet (CV) assay, as described 
previously (27). Absorbance was read spectrophotometrically at 570 nm and isolates 
were grouped based on their level of biomass distribution. Isolates that fell below the 
1st quartile (Q1, OD570 = 0.382) were classed as low biofilm formers (LBF) and strains 
with a biomass greater than the 3rd quartile (Q3, OD570 = 1.192) were deemed as high 
biofilm formers (HBF), as described previously (10, 11).  
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Assessment of biofilm formation upon different denture materials  
Given the artificial nature of standardised C. albicans biofilm testing in RPMI-1640 
medium and polystyrene, we next wanted to assess how selected isolates behaved 
in an environment representative of media and substratum, namely artificial saliva 
(AS) and denture materials. Two clinical isolates (n=1 for LBF and n=1 for HBF) and 
one laboratory strain (SC5314) were selected for assessing their biofilm formation 
upon various denture materials. Isolates were standardised to 107 cells/ml in AS 
(porcine stomach mucins 0.25% (w/v), sodium chloride 0.35% (w/v), potassium 
chloride 0.02 (w/v), calcium chloride dihydrate 0.02% (w/v), yeast extract 0.2% (w/v), 
lab lemco powder 0.1% (w/v), proteose peptone 0.5% (w/v) in double distilled water 
(ddH2O). Urea was then added independently to a final concentration of 0.05% (v/v), 
as previously described (28), and 1 ml added to each well of a 24 well flat-bottomed 
polystyrene plate (Corning Incorporated) containing the following denture substratum 
‘in house’ manufactured discs (13 mm × 1 mm): PMMA MOLLO (Detax dental) and 
UFI (Voco GmbH) soft liners. Biofilms were incubated at 37 °C for 4 h and 24 h 
before washing twice with PBS. As the biofilms were grown on the denture material 
discs, CV could not be used to accurately quantify biomass. Therefore, qPCR was 
used instead. Biofilms were sonicated at 35 kHz for 10 min in 1 ml PBS to remove 
the biomass (29). Samples were centrifuged for 10 min at 10000 x g, the supernatant 
discarded and DNA extracted, as previously described. qPCR was carried out and C. 
albicans cells were quantified using the 18S primers, as previously described.  
 
Antimicrobial treatment of Candida albicans biofilms  
Five C. albicans clinical isolates defined as HBF were selected to test a range of 
OTC denture cleansers (Steradent, Milton and Poligrip) against pre-formed biofilms. 
Isolates were grown in a 96-well flat-bottomed plate for 4 h and 24 h. Two hundred µl 
of these solutions were added to each biofilm and treated, as per defined by the 
manufacturer (10 min for Steradent; 15 min for Milton; 3 min for Poligrip). Untreated 
controls were included for comparison. Following treatment, biofilms were washed 
with PBS and standardised XTT and CV assays were carried out to assess biofilm 
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metabolic activity and biomass, respectively, as described previously (11, 26). 
Scanning electron microscopy (SEM) was performed on the C. albicans biofilms 
grown on PMMA discs to visualise the effects of denture cleansing. Following 4 h 
and 24 h biofilm development, cells were treated with the various denture cleansers 
before carefully washed with PBS, fixed, processed and imaged, as previously 
described (30).  
 
Statistical analysis 
Graph production, data distribution and statistical analysis were performed using 
GraphPad Prism (version 5.01). Data was first assessed to see if it configured to a 
normal distribution and was log transformed where necessary. Student t-tests were 
used to compare candidal loads of healthy and diseased patients. A one-way 
ANOVA with Bonferroni correction was used to measure statistical differences 
between biofilms grown on different denture materials and antimicrobial viability 
testing of the isolates. A Kruskal-Wallis test with Dunn’s post-test was used to 
measure differences in biofilm biomass following different denture cleansers. 
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Results 
Candida burden differs in healthy and DS denture wearers 
The candidal burden colonising the denture surface differed significantly between 
healthy and DS patients (Fig. 1(a); p<0.001). Nonetheless, significant overlap was 
seen between both groups, emphasising the variable nature of candidal biofilm 
formation. Next, the biofilm forming ability of C. albicans denture isolates was 
assessed to evaluate biofilm heterogeneity (Fig. 1b). Isolates differentially formed 
biofilms and were classed as either LBF (Q1, OD570 = 0.382) or HBF (Q3, OD570 = 
1.192). Isolates in between these groups were classed as intermediate biofilm 
formers. Optical densities for healthy patients ranged from 0.09 to 2.81 and from 0.1 
to 2.06 for DS patients, across the 68 isolates tested. No statistical difference was 
observed between healthy and DS patients (p>0.05), with biomass regarded as 
highly variable. This confirms that C. albicans biofilm formation is heterogeneous 
within both groups. 
  
Biofilm biomass and viability is impacted by media and denture substratum 
The impact of denture substratum upon C. albicans biofilm formation was assessed 
next (Fig. 2). At 24 h of biofilm formation, PMMA was the denture material with the 
most significant C. albicans burden (4.21 × 108 CFE), this being 2.8 times and 4.1 
times greater than those of MOLLO (p<0.05) and UFI (p<0.05), respectively. 
Unsurprisingly, C. albicans biomass was significantly more abundant in 24 h biofilms 
than in their 4 h counterparts for each denture substratum; PMMA (p<0.001), 
MOLLO (p<0.05) and UFI (p<0.001). At early stages of biofilm development (4 h), no 
significant candidal burden was observed between the three substrata (p>0.05). 
When biofilm heterogeneity was assessed upon denture substrata, no significant 
differences in C. albicans burden where found between LBF and HBF (data not 
shown).  
 
Treatment of C. albicans biofilms with antimicrobial denture cleansers 
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Finally, three OTC denture cleansers were selected to assess their antifungal activity 
against C. albicans denture biofilms formed by HBF. Milton was the most effective 
cleanser against early biofilms (4 h), reducing biomass by 55%, compared to the 
untreated control (p<0.05), as shown in Fig. 3(a). Poligrip was the second most 
active agent, reducing biomass by 28%. However, Steradent led to an increase in 
the denture biomass by 9%. When mature biofilms were considered (24 h), no 
significant differences were observed when comparing the denture cleanser 
treatments to control biofilms. Unsurprisingly, biomass increased between 4 and 24 
h by 3.3, 2.8, 5.2 and 5 times for the untreated, Steradent, Milton and Poligrip, 
respectively. 
As Milton was the most effective cleanser at disturbing biofilm biomass, it was 
predicted that it would also be the most superior at reducing cellular viability. In this 
study, we have shown that Milton reduces metabolic activity to 17% and 56% in 4 h 
(p<0.001) and 24 h (p<0.05) biofilms, respectively (Fig. 3(b)). The cellular viability at 
4 h was less than that at 24 h, which is most likely due to early biofilms not being as 
complex as their 24 h counterparts, meaning antimicrobials are able to penetrate 
more easily, elicit their activity and reduce viability more readily than the can in 
mature biofilms. Poligrip had little impact on biofilm development, with 90% viable 
cells remaining following treatment of 4 h biofilms, and 78% at 24 h. Interestingly, 
steradent was shown to have the greatest activity against mature biofilms, reducing 
cell viability to 67% at 24 h, compared to no reduction at 4 h (p<0.001). This being 
said, all denture-cleansing regimens were unable to reduced 24 h biofilm viability to 
less that 50%. 
Ultrastructural changes of the treated denture biofilms are illustrated in Fig. 3(c). 
Steradent-treated early biofilms exhibited minimal changes in appearance compared 
to the untreated control. However, at 24 h the biofilms were visually distinct, with a 
fibrous residue evident along the elongated hyphae. This may be a remnant of the 
denture cleanser retained within the biofilm as this was also observed in Milton and 
Poligrip mature biofilms. Interestingly, at 4 h, the hyphal cells appeared to have 
become embedded with the denture acrylic, which may be due to the cleansers 
becoming incorporated within the material and changing the surface topography, as 
suggested elsewhere (31, 32).   
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Discussion 
Despite the vast improvements in oral health over the last 50 years, there still 
remains a large proportion of the adult population that rely on some form of denture 
prosthesis. Wearing a denture can be an immensely uncomfortable experience (33), 
with DS being one of the primary complaints affecting half of denture wearers at 
some point in their lives (3). C. albicans colonisation and subsequent infection of 
mucosa is the principal cause of DS. Here we report that, although biofilm 
heterogeneity impacts overall effective denture cleansing, the quantity of candidal 
yeasts is the main driver of denture stomatitis, not the biofilm phenotype nor denture 
substratum, a finding supported by previous researchers (34).  
It is interesting that heterogeneity is apparent amongst clinical isolates attached to 
dentures, and this phenomenon may play a yet undefined role in DS. Clinically, the 
concept that biofilm heterogeneity may play an important role in determining 
morbidity and mortality levels is worthy of investigation in the context of the oral 
cavity. We have recently reported an association with this phenotype and mortality in 
a Scottish candidaemia cohort (10), so therefore we undertook an analogous 
investigation in a cohort of denture patients. Interestingly, although biofilm 
heterogeneity was observed using established models, an association with patient 
outcomes was not shown. Our inability to demonstrate cause and effect may be 
explained by the fact that this is a relatively mild disease in comparison to 
candidaemia from a severely immunocompromised group. Nevertheless, a positive 
correlation between the absolute candidal numbers and disease was observed, 
suggesting that the physical interaction between large numbers of yeasts and 
hyphae on the denture surface was more important than the phenotype per se. This 
is likely influenced by the diverse microbiota in this environment, which we have 
recently described (22). Indeed, there is increasing evidence that Candida and 
bacteria form polymicrobial biofilms, and that some bacterial species common to the 
oral cavity can enhance the pathogenicity of C. albicans (35-38), and that the 
presence of specific oral bacteria is enough to transform a C. albicans LBF into a 
HBF (39). We have also reported a significant association between lactobacilli and 
yeasts in this context, and this may be more important than C. albicans alone, as is 
the perceived paradigm for this DS. Therefore, the local environment of the denture 
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may play an important role in determining how denture related stomatitis ensues. 
Studies in mice infected with HBF strains of C. albicans were shown to survive 
significantly longer than those infected with LBF strains, suggesting a competitive 
advantage in the host environment (40).  
The microbiology of dentures is dictated by substrata and the surrounding host 
environment. Changing this environment can vastly influence C. albicans biofilm 
formation and survival. Initial adhesion of microbes to dentures is key to their 
pathogenicity, yet denture substrata are highly variable, which may support 
differential adherence and biofilm formation. PMMA is classically used as a denture 
substratum, though its chemistry and topography create a preferential surface for 
biofilm formation (41). Alternative soft liner materials are increasing in popularity as 
they are softer against the palate as well as providing improved masticatory function 
over traditional denture materials (16). Studies comparing microbial growth on hard 
and soft denture liners have shown conflicting results, as one study comparing 
Candida biofilm growth on various soft denture liners found no significant differences 
in the quantity of cells recovered between materials (42). Our study however, found 
that, although there was no significant difference in microbial colonisation during 
early biofilm formation, PMMA became the most prone substratum to biofilm 
formation at later stages of development, regardless of the isolate’s phenotype. 
Interestingly, analysis of biofilms forming on PMMA and soft liners at 1, 7 and 14 
days, found no significant differences in adhesion at 24 h, yet colonisation on hard 
acrylic was observed to be lower at all time points (43). A possible explanation as to 
why we are seeing higher numbers on PMMA is because soft liners are even more 
porous in nature than hard acrylics (44) and thus higher numbers of microbes may 
become imbedded in these cracks and crevices. Therefore, even a powerful method 
such as sonication may not be sufficient enough to completely dislodge the 
microorganisms hidden within these soft liners. To the authors’ knowledge, this is the 
first study to use molecular methods such as qPCR to quantify biofilms on denture 
acrylics, in order to give more accurate quantitative microbial counts. However, the 
vast majority of studies in this area have relied on culturing and staining techniques 
for quantification, and thus the methods used may account for the differences seen 
across studies (42, 43, 45).  
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Currently, there is no universal method for cleaning dentures, where it is common to 
find the recommended method varies from dentist to dentist. There are numerous 
OTC denture cleansers available. Therefore, we selected three of the most popular 
brands - Steradent, Milton and Poligrip - to assess their antifungal activity. Milton 
was the most effective treatment at reducing biomass and cell viability on early (4 h) 
biofilms. Yet, it did not completely eradicate the biofilm. Such results are interesting 
given previous findings showing that this treatment completely inhibited biofilm 
formation at 4 h (29). Methodological constraints due to conventional c.f.u. 
quantification may explain this, since it has been recently demonstrated counting 
c.f.u. can give false negative results. By using live/dead qPCR on the same 
experiment, ~ 1 x 105 cells/ml viable cells were detected, where c.f.u. counting 
detected no live cells (21). Moreover, as the biofilms matured, Milton lost its effect, 
most likely because of the thicker biofilm, which would be more difficult to penetrate 
and disrupt. Yet, previous experiments have shown that denture cleansers and 
antimicrobial mouthwashes can significantly reduce the viability of mature C. 
albicans denture isolates (19, 46). These studies do not confirm the biofilm forming 
capacity of the assayed isolates, whereas our study used known HBFs, which could 
explain why our isolates were more resistant to treatment, a phenomenon reported 
elsewhere with these phenotypes (11). Moreover, previous studies have shown that 
C. albicans is not completely eradicated from the denture, even when using various 
denture cleansing treatments (29). Our collection of SEM images supports this as 
they show that C. albicans cells remain on the denture acrylic irrespective of 
treatment. We cannot guarantee that all these cells are dead and therefore it is likely 
that some are still alive and could begin to recolonise the denture when placed back 
into the mouth. Furthermore, full penetration of the biofilms is unlikely due to the 
protective effects against antimicrobials, such as efflux pumps and extracellular 
glucans, provided by the ECM”. (30, 47).  
In conclusion, it was demonstrated that C. albicans isolates reside on dentures on 
DS affected individuals in higher numbers. These isolates demonstrated 
heterogeneity in their biofilm forming abilities. However, HBFs were not more 
common to DS sufferers. Therefore, although the particular strain isolated may 
strongly influence the development of disease, other factors are also involved. The 
surrounding environment has a strong influence as we demonstrated that some 
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materials are better at supporting C. albicans biofilm growth. Furthermore, 
antimicrobial denture cleansing treatments do not fully eradicate HBF C. albicans 
isolates, leaving behind live cells, which can disperse and recolonise.  Therefore, in 
terms of future studies investigating C. albicans biofilms and denture related disease, 
it has to be recognised that various factors influence disease and that it is the 
culmination of these that determines the pathogenic outcome.  
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Figure 1: Quantification of Candida species and biomass from clinical isolates. 
The denture sonicates of healthy or denture stomatitis (DS) individuals were 
screened for Candida presence (A). Both horizontal lines represent the mean of 
each group, with the asterisks representing significant differences (***p<0.001). Low 
biofilm formers (LBF) and high biofilm formers (HBF) isolates were defined, 
respectively, by the lower and upper quartiles, as defined by the dotted lines (B). 
 
Figure 2: Impact of the tested denture substratum on Candida albicans biofilm 
formation. C. albicans SC5314, one low biofilm former and one high biofilm former 
were grown as biofilms on PMMA, MOLLO and UFI denture materials, to assess 
biofilm formation at 4 h and 24 h. Data represents mean ± SD of three isolates 
combined together. 24 h data was compared to 4 h counterparts (#p<0.05, 
###p<0.001). Significant differences were also observed between different denture 
substratum at 24 h (*p<0.05). 
 
Figure 3: Assessing antimicrobial denture cleansers on Candida albicans 
biofilm formation. The effects of three over-the-counter (OTC) denture cleansers 
on C. albicans biofilm formation were assessed by biomass (A) and viability (B) at 4 
h and 24 h. All images are shown at 1000× magnifications (C). Scale bars represent 
20 µm. Data represents mean ± SD. Significant differences were observed when 
comparing each cleanser at 4 h to their 24 h counterparts (##p<0.01 and ###p<0.001), 
as well as comparing cleansers to one another  (*p<0.05, **p<0.01 and ***p<0.001).  
